• Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

    Source: Buzz FX / 24 Nov 2024 02:26:10   America/New_York


    Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat November 24, 2024 Share Link copied to clipboard. Shares of Halozyme Therapeutics, Inc.
    Read more...
Share on,